| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $146K | +69.8% | +15.9% |
| Cost of Revenue | $291K | +809.4% | +254.9% |
| Gross Profit | -$145K | -368.5% | -429.5% |
| R&D Expense | $858K | +31.0% | +103.3% |
| SG&A Expense | $1.1M | +4.1% | +30.0% |
| Operating Income | -$2.5M | -28.4% | -73.5% |
| Net Income | -$2.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.5M | +191.4% | +57.6% |
| Accounts Receivable | $19K | +46.2% | +111.1% |
| Inventory | $4K | -98.6% | -99.5% |
| Current Assets | $3.7M | +103.0% | +18.2% |
| Total Assets | $6.2M | +38.2% | +83.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | — |
| Capital Expenditures | $13K | — | — |
| Investing Cash Flow | -$556K | — | — |
| Financing Cash Flow | $6.7M | — | — |
| Free Cash Flow | -$4.7M | — | — |
| -34.4% |
| -81.4% |
| EPS (Basic) | -$1.97 | +10.0% | -756.5% |
| $638K |
| -22.3% |
| +13.9% |
| Total Liabilities | $638K | -22.3% | +13.9% |
| Stockholders' Equity | $5.6M | +51.6% | +97.3% |